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ABSTRACT.  The seroepidemiological survey of cats conducted in northern part of Taiwan in 1998 revealed that the positive rate of feline
immunodeficiency virus (FIV)-infection was 21.9% (7/32) and the rate was much higher than those of previous reports.  We succeeded in
isolation of three strains of FIV from peripheral blood mononuclear cells of the blood samples.  Nucleotide sequences of the env variable
V3 to V5 region of the strains revealed that the isolates from distinct areas belong to subtype C.  These data together with our previous
report (Inada et al. 1997. Arch. Virol., 142: 1459–1467) indicate that FIV subtype C is prevalent in northern part of Taiwan.—KEY WORDS:
feline immunodeficiency virus, subtype, Taiwan.
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immunofluorescence (IF) assay as described previously [9].
Peripheral blood mononuclear cells (PBMCs) were purified
by centrifugation over Ficoll-Paque (Amersham Pharmacia
Biotech, Buckinghamshire, U.K.).  The PBMCs were
stimulated with 10 µg/ml of concanavalin-A (Amersham
Pharmacia Biotech) for three days as described previously
[8] and then cocultured with MYA-1 cells, an interleukin-2-
dependent feline T-lymphoblastoid cell line which is highly
sensitive to FIV [8].  Cultures were maintained in RPMI
1640 growth medium supplemented with 10% heat-
inactivated fetal calf serum (FCS), antibiotics, 50 µM
2-mercaptoethanol, 2 µg/ml polybrene and 100 units/ml of
recombinant human interleukin-2 at 37°C in a humidified
atmosphere of 5 % CO2 in air.  The medium was replaced
with fresh one every 2–4 days, and 12 days after
cocultivation of the PBMCs with MYA-1 cells, the cells
were harvested for the indirect IF assay.  Antigens of FIV
in the cultured cells were examined by the indirect IF assay
using a serum of an FIV-infected specific pathogen-free cat.
Two weeks after cocultivation, total cellular DNA was
extracted from the cultures by QIAamp Blood Kit (QIAGEN
GmbH, Hilden, Germany).  FIV-specific DNAs were
amplified by polymerase chain reaction (PCR) using a
primer pair HV3f and HV5r as described previously [12].
The primer HV3f corresponds to nucleotide position 7,322
to 7,344 and the primer HV5r to position 8,049 to 8,027,
according to the published sequence of FIV TM2 strain [7].
The amplified fragments were subjected to the sequencing
analysis.
Sequence react ions were performed by the
dideoxynucleotide chain termination method using Big Dye
Terminator cycle sequencing kit (Applied Biosystems Inc.
(ABI), CA, U.S.A.) according to the manufacturer’s
instructions.  The sequencing samples were resolved on an
automated DNA sequencer (ABI model 377A).  The
phylogenetic analysis was carried out using GENETYX-
MAC ver. 9.0 (SOFTWARE DEVELOPMENT Co., Ltd.,
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Feline immunodeficiency virus (FIV) was first isolated
in the United States in 1986 from a cat with an acquired
immunodeficiency syndrome (AIDS)-like disease [13].  FIV
infection in cats has been associated with AIDS-related
diseases including stomatitis, gingivitis, anemia and
neurological dysfunction [10, 13].  FIV has considerable
sequence variation in the env region of the genome [2–4, 7,
12, 14].  Studies on the sequence variation of FIV env
variable V3 to V5 region revealed that FIV isolates can be
divided into at least five subtypes (A to E) [4, 12, 14].
Seroepidemiological surveys conducted in several countries
demonstrated that FIV is prevalent worldwide, and the
prevalence of FIV infection in cats varied from 1% to 15%
in healthy cats and from 3% to 44% in diseased cats [10].
In Taiwan, the first survey reported in 1990 revealed that
FIV-positive rate was 2.5% [5].  Previously, we reported
that the FIV-positive rate in Taiwan was 4% in samples
collected in 1993 and 1994 [6].
In 1995, we succeeded in isolation of four strains of FIV
from cats in Taipei and determined nucleotide sequence of
the env V3 to V5 region of the strains [3].  Quite
interestingly, the sequence data revealed that all the strains
belonged to subtype C which had been reported only in
Canada [14].  However, it remained to be determined
whether FIV in distinct areas of Taiwan also belongs to
subtype C.  In this study, we isolated additional three strains
of FIV from cats in two distinct areas in northern part of
Taiwan, and the nucleotide sequences of the env V3 to V5
region of the isolates were determined.
Blood samples from 21 and 11 cats in shelters in Taipei
and Tam-Sui, respectively, were used in this study.
Antibodies against FIV were detected by the indirect
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Tokyo, Japan).
The GenBank accession numbers for the FIV env
sequences included in this study were Aomori-1 (D37816),
Aomori-2 (D37817),  CABCpady02C (U02392),
CABCpbar01C (U02393), CABCpbar02C (U02394),
CABCpbar03C (U02395),  CABCpbar07C (U02397),
CA.Dixon (L00608), CA.PPR (M36968), Dutch4 (X69498),
Dutch6 (X69499), Dutch32 (M73965), DutchK1 (M73964),
DutchUtr (X60725),  EngUK8 (X69496), FrenchWo
(L06312), Fukuoka (D37815), ItalyM1 (X69500), ItalyM4
(X69503), LP3 (D84496), LP20 (D84498), Petaluma
(M25381), ScotUK2 (X69494), Sendai-1 (D37813), Sendai-
2 (D37814), Shizuoka (D37811), SwissZ1 (X57002),
SwissZ2 (X57001), TI-1 (AB016025), TI-2 (AB016026),
TI-3 (AB016027), TI-4 (AB016028), TM2 (M59418),
USCAalemy01A (U02404), USCAhnky02A (U02400),
USCAsam_01A (U02410), USCAtt__01A (U02411),
USCAtt__09A (U02413), USCAtt__10A (U02414),
USCAzepy01A (U02417), USILbrny03B (U02418),
USMAsboy03B (U02419), USOKlgrl02B (U02421),
USTXmtex03B (U02422), WalesUK14 (X69497), and
Yokohama (D37812).
Seroepidemiological survey revealed that the FIV-positive
rate was 9.5% (2 of 21) and 45.5% (5 of 11) in Taipei and
Tam-Sui areas, respectively.  The overall FIV-positive rate
in this study was 21.9%, and the rate was much higher than
those of previous reports [5, 6].  Since the number of
samples analyzed is small and the samples are collected in
only two restricted areas, we can not conclude that the FIV-
positive rate observed here is representative of the cat
population in Taiwan.  However, our data indicate that FIV
infection is prevalent in northern part of Taiwan.
The cocultured samples from three FIV-seropositive cats
were shown to be positive for FIV-specific antigens by the
indirect IF assay.  FIV-specific provirus was also detected
in the three cultures by the PCR analysis.  The FIV isolates
were designated as MU-1, MU-2 and MU-3 strains.  MU-1
was isolated from a cat in Taipei, while MU-2 and MU-3
were from cats in Tam-Sui.
Next, we determined the nucleotide sequences of the env
V3-V5 region of the strains.  The predicted amino acid
sequences of the region of MU-1, MU-2 and MU-3 strains
were aligned along with 627bp sequences representative of
A and B env subtypes reported previously [7, 11] (Fig. 1).
The cell tropism for CRFK cells depends on a single
mutation of the 407th amino acid residue in env V3 region.
The mutation from a lysine to a glutamic acid at the position
converts a CRFK-tropic virus to a non-CRFK-tropic virus
[15].  In this study, the predicted amino acid residue at the
position of the Taiwanese isolates was glutamic acid
indicating their lack of ability to infect CRFK cells.  As
shown in Fig. 2, phylogenetic analysis revealed that the
newly isolated Taiwanese strains belonged to the subtype C
group and clustered with the other Taiwanese isolates.  The
reason for the prevalence of the subtype C in Taiwan is still
unknown, however it might be possible that subtype C FIV
was introduced from Canada in recent years and is spreading
in the cat population in northern part of Taiwan.
It was reported that subtype A seems more pathogenic
Fig. 2. Phylogenetic tree of the predicted amino acid
sequences of the V3 to V5 region of FIV env.
Fig. 1. Alignment of the predicted amino acid sequences
encompassing the V3 to V5 region of FIV env. Identical
amino acids at given positions are represented by dots (.),
gaps are represented by dashes (–). The nucleotide sequence
data will appear in the DDBJ/EMBL/GenBank nucleotide
sequence databases with the accession numbers AB016666
to AB016668.
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than subtype B according to the ratio of non-synonymous
and synonymous substitutions (N:S ratio) in the amino acid
sequence within the subtypes [12, 14].  However, as for
subtypes C, D and E, there are little sequence data available,
and it is difficult to evaluate the N:S ratios deduced from
the limited number of the sequence data.  It was reported
that the subtype C FIV strain CABCpady00C could induce
accelerated FIV disease by in vivo passage of acute-phase
virus [1].  To date, it is unknown whether the Taiwanese
isolates cause severe FIV-related diseases.  Although further
clinical studies on FIV-infected cats in Taiwan are necessary
to know the pathogenicity of the subtype, our sequence data
will be useful to calculate the N:S ratio and to know the
relationship between the ratio and pathogenicity of the
subtype.
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